SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. to the U.S. Securities and Exchange Commission. The reporting period covers holdings as of June 30, 2023. This document discloses Alphabet's equity securities held in the United States, detailing the number of shares, value, and voting authority for each position.
Key Financial Metrics and Portfolio Composition
The filing does not report Alphabet's internal revenue, profit, or cash flow. Instead, it details the value of Alphabet's external investment portfolio. Key observations include:
- Portfolio Focus: The disclosed holdings are heavily concentrated in the biotechnology, healthcare, and technology sectors.
- Top Holdings by Value:
- CrowdStrike Holdings Inc.: $188,534,522 (1,283,683 shares)
- UiPath Inc.: $226,388,338 (13,662,543 shares)
- Verve Therapeutics Inc.: $194,409,168 (10,368,489 shares)
- Prime Medicine, Inc.: $173,785,595 (11,862,498 shares)
- Oscar Health Inc.: $172,038,669 (21,344,748 shares)
- Voting Authority: Alphabet reports "Sole" voting authority for the majority of these positions, indicating direct control over voting decisions for these specific securities.
Material Changes and Comparisons
The filing text provided is a snapshot of holdings as of June 30, 2023. It does not provide comparative data against the prior quarter (March 31, 2023) or prior year. Consequently, material changes in position size, new acquisitions, or divestitures cannot be determined from this document alone.
Guidance, Risks, and Contingencies
Form 13F filings are statutory disclosure documents and do not contain management commentary, forward-looking guidance, risk factors, or contingency plans regarding Alphabet's own business operations. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total aggregate value of Alphabet's disclosed equity portfolio to assess the scale of its external investment strategy.
- Compare these holdings against Alphabet's previous 13F filings to identify new entries or significant exits in the biotech and tech sectors.
- Confirm the "Sole" vs. "Shared" voting authority status to understand the level of influence Alphabet exerts on these investee companies.
- Note that this filing excludes Alphabet's primary operating businesses (Google, Cloud, etc.) and focuses solely on its investment arm's equity positions.